1-10 of 10
Robert J. Fox
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis

Amber Salter, PhD, MPH, Robert J. Fox, MD, Gary Cutter, PhD, Ruth Ann Marrie, MD, PhD, Kate E. Nichol, PhD ...
Journal: International Journal of MS Care
Int J MS Care (2021) 23 (6): 245–252.
https://doi.org/10.7224/1537-2073.2021-036
Published: 29 December 2021
View articletitled, A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis
Open the PDF for A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis in another window
Includes: Supplementary data
Journal Articles

NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights

Ruth Ann Marrie, MD, PhD, Gary R. Cutter, PhD, Robert J. Fox, MD, MSc, Timothy Vollmer, MD, Tuula Tyry, PhD ...
Journal: International Journal of MS Care
Int J MS Care (2021) 23 (6): 276–284.
https://doi.org/10.7224/1537-2073.2020-133
Published: 29 December 2021
View articletitled, NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights
Open the PDF for NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights in another window
Journal Articles

Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate

Amber Salter, PhD, MPH, Samantha Lancia, MS, Gary Cutter, PhD, Robert J. Fox, MD, PhD, Ruth Ann Marrie, MD, PhD ...
Journal: International Journal of MS Care
Int J MS Care (2021) 23 (6): 239–244.
https://doi.org/10.7224/1537-2073.2020-109
Published: 09 July 2021
View articletitled, Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate
Open the PDF for Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate in another window
Includes: Supplementary data
Journal Articles

Vitamin D Levels and Visual System Measurements in Progressive Multiple Sclerosis: A Cross-sectional Study

Justin R. Abbatemarco, MD, Robert J. Fox, MD, Hong Li, BS, Robert A. Bermel, MD, Daniel Ontaneda, MD, PhD
Journal: International Journal of MS Care
Int J MS Care (2020) 23 (2): 53–58.
https://doi.org/10.7224/1537-2073.2020-005
Published: 28 April 2020
View articletitled, Vitamin D Levels and Visual System Measurements in Progressive Multiple Sclerosis: A Cross-sectional Study
Open the PDF for Vitamin D Levels and Visual System Measurements in Progressive Multiple Sclerosis: A Cross-sectional Study in another window
Journal Articles

Shared Decision Making and Autonomy Among US Participants with Multiple Sclerosis in the NARCOMS Registry

Stacey S. Cofield, PhD, Nina Thomas, MPH, Tuula Tyry, PhD, Robert J. Fox, MD, Amber Salter, PhD
Journal: International Journal of MS Care
Int J MS Care (2017) 19 (6): 303–312.
https://doi.org/10.7224/1537-2073.2016-091
Published: 01 November 2017
View articletitled, Shared Decision Making and Autonomy Among US Participants with Multiple Sclerosis in the NARCOMS Registry
Open the PDF for Shared Decision Making and Autonomy Among US Participants with Multiple Sclerosis in the NARCOMS Registry in another window
Includes: Supplementary data
Journal Articles

Dimethyl Fumarate: A Review of Efficacy and Practical Management Strategies for Common Adverse Events in Patients with Multiple Sclerosis

J. Theodore Phillips, MD, PhD, Stephanie Agrella, NP, Robert J. Fox, MD
Journal: International Journal of MS Care
Int J MS Care (2017) 19 (2): 74–83.
https://doi.org/10.7224/1537-2073.2015-086
Published: 01 March 2017
View articletitled, Dimethyl Fumarate: A Review of Efficacy and Practical Management Strategies for Common Adverse Events in Patients with Multiple Sclerosis
Open the PDF for Dimethyl Fumarate: A Review of Efficacy and Practical Management Strategies for Common Adverse Events in Patients with Multiple Sclerosis in another window
Includes: Supplementary data
Journal Articles

Disability Progression After Switching from Natalizumab to Fingolimod or Interferon Beta/Glatiramer Acetate Therapies: A NARCOMS Analysis

Stacey S. Cofield, PhD, Robert J. Fox, MD, Tuula Tyry, PhD, Amber R. Salter, PhD, Denise Campagnolo, MD, MS
Journal: International Journal of MS Care
Int J MS Care (2016) 18 (5): 230–238.
https://doi.org/10.7224/1537-2073.2014-113
Published: 01 September 2016
View articletitled, Disability Progression After Switching from Natalizumab to Fingolimod or Interferon Beta/Glatiramer Acetate Therapies: A NARCOMS Analysis
Open the PDF for Disability Progression After Switching from Natalizumab to Fingolimod or Interferon Beta/Glatiramer Acetate Therapies: A NARCOMS Analysis in another window
Journal Articles

Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis

Jonathan Calkwood, MD, Timothy Vollmer, MD, Robert J. Fox, MD, FAAN, Ray Zhang, PhD, Mark Novas, MD ...
Journal: International Journal of MS Care
Int J MS Care (2016) 18 (3): 138–146.
https://doi.org/10.7224/1537-2073.2015-020
Published: 01 May 2016
View articletitled, Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
Open the PDF for Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis in another window
Journal Articles

Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate

J. Theodore Phillips, MD, PhD, Krzysztof Selmaj, MD, PhD, Ralf Gold, MD, Robert J. Fox, MD, Eva Havrdova, MD ...
Journal: International Journal of MS Care
Int J MS Care (2015) 17 (5): 236–243.
https://doi.org/10.7224/1537-2073.2014-069
Published: 01 September 2015
View articletitled, Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate
Open the PDF for Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate in another window
Journal Articles

Treatment Discontinuation and Disease Progression with Injectable Disease-Modifying Therapies: Findings from the North American Research Committee on Multiple Sclerosis Database

Robert J. Fox, MD, Amber R. Salter, MPH, Tuula Tyry, PhD, Jennifer Sun, MS, Xiaojun You, PhD ...
Journal: International Journal of MS Care
Int J MS Care (2013) 15 (4): 194–201.
https://doi.org/10.7224/1537-2073.2012-034
Published: 31 December 2013
View articletitled, Treatment Discontinuation and Disease Progression with Injectable Disease-Modifying Therapies: Findings from the North American Research Committee on Multiple Sclerosis Database
Open the PDF for Treatment Discontinuation and Disease Progression with Injectable Disease-Modifying Therapies: Findings from the North American Research Committee on Multiple Sclerosis Database in another window